We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$15.5B
AUM Growth
+$2.94B
Cap. Flow
+$1.45B
Cap. Flow %
9.35%
Top 10 Hldgs %
30.63%
Holding
2,230
New
735
Increased
384
Reduced
378
Closed
720

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$614M
2
AAPL icon
Apple
AAPL
+$443M
3
BLD
TopBuild
BLD
+$391M
4
SPCX
SpaceX
SPCX
+$329M
5
PEN icon
Penumbra
PEN
+$203M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.96B
2
NVDA icon
NVIDIA
NVDA
+$425M
3
SNDK
Sandisk
SNDK
+$88M
4
SO icon
Southern Company
SO
+$80.6M
5
PPL
PPL Corp
PPL
+$74.1M

Sector Composition

Rank Sector Weight
1 Technology 16.4%
2 Industrials 13.64%
3 Consumer Discretionary 9.5%
4 Healthcare 7.9%
5 Financials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KKR icon
1826
KKR & Co
KKR
$97.4B
-7,139
Closed -$660K
KLAC icon
1827
CALL
KLA
KLAC
$240B
-2,000
Closed -$294K
KODK icon
1828
Kodak
KODK
$963M
-98,155
Closed -$888K
KRC icon
1829
Kilroy Realty
KRC
$4.25B
-95,104
Closed -$2.68M
KRG icon
1830
Kite Realty
KRG
$5.24B
-235,968
Closed -$5.79M
KRNY icon
1831
Kearny Financial
KRNY
$612M
-82,477
Closed -$623K
KRO icon
1832
KRONOS Worldwide
KRO
$944M
-43,219
Closed -$284K
KURA icon
1833
Kura Oncology
KURA
$1.06B
-229,728
Closed -$1.87M
KWR icon
1834
Quaker Houghton
KWR
$2.81B
-8,167
Closed -$1.01M
KYMR icon
1835
Kymera Therapeutics
KYMR
$9.96B
-28,318
Closed -$2.36M
MZTI
1836
The Marzetti Company
MZTI
$3.06B
-63,764
Closed -$8.82M
LAUR icon
1837
Laureate Education
LAUR
$5.16B
-81,803
Closed -$2.85M
LAZ icon
1838
CALL
Lazard
LAZ
$4.3B
-75,000
Closed -$3.19M
LBRDK
1839
DELISTED
Liberty Broadband Class C
LBRDK
-104,357
Closed -$5.25M
LCTX icon
1840
Lineage Cell Therapeutics
LCTX
$273M
-21,157
Closed -$33.4K
LDOS icon
1841
Leidos
LDOS
$17.7B
-43,428
Closed -$6.75M
LE icon
1842
Lands' End
LE
$375M
-60,194
Closed -$677K
LEG icon
1843
Leggett & Platt
LEG
$1.29B
-119,663
Closed -$1.18M
LEGH icon
1844
Legacy Housing
LEGH
$681M
-22,040
Closed -$450K
LII icon
1845
Lennox International
LII
$13.9B
-19,917
Closed -$9.24M
LITE icon
1846
Lumentum
LITE
$77.7B
-29,686
Closed -$26.5M
LMND icon
1847
Lemonade
LMND
$4.13B
-49,464
Closed -$3.1M
LNC icon
1848
Lincoln National
LNC
$8.07B
-70,020
Closed -$2.49M
LNG icon
1849
Cheniere Energy
LNG
$57.3B
-20,877
Closed -$5.92M
LPX icon
1850
Louisiana-Pacific
LPX
$5.12B
-39,587
Closed -$2.88M

Similar funds

Michael Gelband's Q2 2026 Portfolio in Review

As of Q2 2026, Michael Gelband held 2,230 positions worth $15.5B, up 23% from $12.6B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Michael Gelband deployed $1.45B of net new capital in Q2 2026, opening 735 new positions and adding to 384 existing holdings. Its largest new stake was SpaceX: 1,938,935 shares worth $331M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Tesla, an estimated $1.96B trimmed.

  • Michael Gelband's largest Q2 2026 buy was SpaceX: 1,938,935 shares worth $331M.
  • Michael Gelband added most to Amazon in Q2 2026, an estimated $614M increase.
  • Michael Gelband's biggest Q2 2026 reduction was Tesla, cutting an estimated $1.96B.
  • Michael Gelband fully exited Southern Company in Q2 2026, selling an estimated $80.6M.
  • Michael Gelband's ten largest holdings make up 31% of its $15.5B portfolio in Q2 2026.
  • Michael Gelband opened 735 new positions and closed 720 in Q2 2026.
  • Michael Gelband's portfolio value rose 23% quarter-over-quarter to $15.5B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.